Healthcare -
Biotechnology - NASDAQ - US
$ 6.195
-13.2 %
$ 974 M
Market Cap
-4.8
P/E
OCUL - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities OCUL - Ocular Therapeutix, Inc.
170 M
LAST VALUE
671.80%
2 YEAR CAGR
19.86%
5 YEAR CAGR
38.20%
10 YEAR CAGR